Guidant gets FDA approval for Lifestream:

This article was originally published in Clinica

11 Dec 1995
News

Executive Summary

US cardiology company Guidant has received US FDA approval to market its ACS over-the-wire Lifestream coronary dilatation catheter. Advanced Cardiovascular Systems, part of Guidant's vascular intervention group, manufactures the device and distribution of the product will begin at once. Guidant says the ACS OTW Lifestream has a 26% reduced crossing profile compared with the ACS Stack 40S catheter and allows physicians to reach and cross more difficult lesions.

Already Registered? Sign in to continue reading.

New to Medtech Insight? Start a free trial today!

Table
View full table

Topics

Industries
Medical Device

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

Medical Device

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

MT094464

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

MT094464

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Guidant gets FDA approval for Lifestream:

News

Executive Summary

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert